Breaking News
Get 40% Off 0
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did. Read how
Close

SAB Biotherapeutics Inc (SABS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow SAB Biotherapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.010 +0.010    +0.25%
10/05 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 4,830
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 4.010 - 4.205
SAB Biotherapeutics 4.010 +0.010 +0.25%

SABS Recent Sentiments

 
This page contains information on users’ sentiments for the SAB Biotherapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Mar 25, 2024 Ian Pelliccia   4.470 Apr 19, 2024 @ 4.290 -4.03%
Mar 25, 2024 Andreas Schatz   4.800 Apr 19, 2024 @ 4.290 -10.63%
Nov 28, 2023 Suhar Yanto   0.880 Dec 22, 2023 @ 0.731 -16.93%
Apr 27, 2023 רונן בן   0.975 Nov 30, 2023 @ 0.870 -10.77%
Apr 19, 2023 Robbert Kuipers   0.910 Nov 30, 2023 @ 0.870 -4.40%
Apr 19, 2023 Robbert Kuipers   0.938 Apr 19, 2023 @ 0.938 0.00%
Apr 19, 2023 Robbert Kuipers   0.938 Apr 19, 2023 @ 0.938 0.00%
Apr 19, 2023 Robbert Kuipers   1.090 Apr 19, 2023 @ 0.938 -13.94%
Apr 18, 2023 Harikumar Unnikrishna   1.060 Nov 30, 2023 @ 0.870 -17.92%
Apr 18, 2023 Robbert Kuipers   1.021 Apr 19, 2023 @ 1.090 +6.76%
Apr 18, 2023 Robbert Kuipers   1.028 Apr 18, 2023 @ 1.028 0.00%
Apr 18, 2023 Robbert Kuipers   1.030 Apr 18, 2023 @ 1.028 -0.19%
Apr 18, 2023 Robbert Kuipers   1.030 Apr 18, 2023 @ 1.030 0.00%
Apr 18, 2023 Robbert Kuipers   0.930 Apr 18, 2023 @ 1.030 +10.75%
Apr 18, 2023 Robbert Kuipers   0.961 Apr 18, 2023 @ 0.930 -3.23%
Apr 18, 2023 Robbert Kuipers   0.961 Apr 18, 2023 @ 0.961 0.00%
Apr 18, 2023 Robbert Kuipers   0.961 Apr 18, 2023 @ 0.959 -0.21%
Apr 18, 2023 Robbert Kuipers   0.940 Apr 18, 2023 @ 0.959 +2.02%
Apr 18, 2023 Robbert Kuipers   0.945 Apr 18, 2023 @ 0.945 0.00%
Apr 18, 2023 Robbert Kuipers   0.950 Apr 18, 2023 @ 0.950 0.00%
Apr 18, 2023 Robbert Kuipers   0.950 Apr 18, 2023 @ 0.950 0.00%
Apr 18, 2023 Robbert Kuipers   0.959 Apr 18, 2023 @ 0.950 -0.94%
Apr 18, 2023 Robbert Kuipers   0.950 Apr 18, 2023 @ 0.950 0.00%
Apr 18, 2023 paul samudio   1.120 Nov 30, 2023 @ 0.870 -22.32%
Apr 18, 2023 Robbert Kuipers   0.945 Apr 18, 2023 @ 0.950 +0.53%
Apr 18, 2023 Robbert Kuipers   0.945 Apr 18, 2023 @ 0.945 0.00%
Apr 13, 2023 Cruzeiro dos Santos   0.708 Apr 17, 2023 @ 0.709 -0.14%
Apr 13, 2023 Jesus Garcia   0.704 May 09, 2023 @ 0.980 -39.20%
Mar 23, 2023 John Danielson   0.509 Apr 14, 2023 @ 0.725 +42.53%
Nov 01, 2022 Robbert Kuipers   1.000 Nov 07, 2022 @ 1.050 +5.00%
Oct 03, 2022 Cruzeiro dos Santos   0.711 Oct 10, 2022 @ 0.830 -16.74%
Sep 27, 2022 yann Henrot   0.720 Oct 03, 2022 @ 0.730 +1.39%
Sep 20, 2022 ignatius zungu   0.792 Oct 14, 2022 @ 0.795 +0.39%
Jun 23, 2022 Robbert Kuipers   1.250 Jun 27, 2022 @ 1.415 +13.20%
Jun 21, 2022 Robbert Kuipers   1.345 Jun 27, 2022 @ 1.415 +5.20%
Apr 01, 2022 Rui Monteiro   3.760 Apr 04, 2022 @ 3.280 -12.77%
Mar 31, 2022 Piero Santoro   3.750 Apr 04, 2022 @ 3.460 +7.73%
Mar 31, 2022 ניר שריד   4.010 Apr 22, 2022 @ 2.530 -36.91%
Mar 16, 2022 crude oil   1.770 Apr 08, 2022 @ 2.920 +64.97%
Mar 07, 2022 Ali Jaber   2.355 Mar 07, 2022 @ 2.355 0.00%
Mar 02, 2022 davide vullo   2.850 Mar 25, 2022 @ 1.950 +31.58%
Mar 02, 2022 אריק קאופמן   2.357 Mar 25, 2022 @ 1.950 -17.27%
Jan 06, 2022 Caleb Bickham   7.680 Jan 28, 2022 @ 5.180 +32.55%
Dec 06, 2021 colin goostree   9.700 Dec 31, 2021 @ 7.810 -19.48%
Dec 01, 2021 Caleb Bickham   11.370 Dec 24, 2021 @ 8.750 -23.04%
Nov 26, 2021 Robbert Kuipers   10.000 Dec 17, 2021 @ 8.780 -12.20%
Nov 23, 2021 Josh Blindert   8.900 Dec 17, 2021 @ 8.780 -1.35%
Nov 22, 2021 Josh Blindert   9.900 Nov 22, 2021 @ 9.930 +0.30%
Nov 09, 2021 colin goostree   9.590 Dec 03, 2021 @ 9.880 +3.02%
Oct 26, 2021 colin goostree   8.530 Nov 04, 2021 @ 8.300 -2.70%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SABS Comments

Write your thoughts about SAB Biotherapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Javi Sempere
Javi Sempere Oct 15, 2021 8:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
oooh Van
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email